JPH0374384A - ３ｒ‐（３‐カルボキシベンジル）‐６‐（５‐フルオロ‐２‐ベンゾチアゾリル）メトキシ‐４ｒ‐クロマノールの光学分割方法 - Google Patents

３ｒ‐（３‐カルボキシベンジル）‐６‐（５‐フルオロ‐２‐ベンゾチアゾリル）メトキシ‐４ｒ‐クロマノールの光学分割方法

Info

Publication number
JPH0374384A
JPH0374384A JP2204937A JP20493790A JPH0374384A JP H0374384 A JPH0374384 A JP H0374384A JP 2204937 A JP2204937 A JP 2204937A JP 20493790 A JP20493790 A JP 20493790A JP H0374384 A JPH0374384 A JP H0374384A
Authority
JP
Japan
Prior art keywords
quinine
salt
formula
compound
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2204937A
Other languages
English (en)
Japanese (ja)
Inventor
Robert C Friedmann
ロバート・クレイトン・フリードマン
George J Quallich
ジヨージ・ジヨージフ・クオリツチ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Inc
Original Assignee
Pfizer Corp Belgium
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Inc filed Critical Pfizer Corp Belgium
Publication of JPH0374384A publication Critical patent/JPH0374384A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2204937A 1989-08-04 1990-08-01 ３ｒ‐（３‐カルボキシベンジル）‐６‐（５‐フルオロ‐２‐ベンゾチアゾリル）メトキシ‐４ｒ‐クロマノールの光学分割方法 Pending JPH0374384A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US389715 1982-06-18
US07/389,715 US4987231A (en) 1989-08-04 1989-08-04 Optical resolution method for 3R-(3-carboxybenzyl)-6-(5-fluoro-2-benzothiazolyl)methoxy-4R-chromanol

Publications (1)

Publication Number Publication Date
JPH0374384A true JPH0374384A (ja) 1991-03-28

Family

ID=23539421

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2204937A Pending JPH0374384A (ja) 1989-08-04 1990-08-01 ３ｒ‐（３‐カルボキシベンジル）‐６‐（５‐フルオロ‐２‐ベンゾチアゾリル）メトキシ‐４ｒ‐クロマノールの光学分割方法

Country Status (23)

Country Link
US (1) US4987231A (cs)
EP (1) EP0411813A1 (cs)
JP (1) JPH0374384A (cs)
KR (1) KR920011021B1 (cs)
CN (1) CN1024550C (cs)
AU (1) AU613838B2 (cs)
CA (1) CA2022611C (cs)
CZ (1) CZ279737B6 (cs)
DD (1) DD296924A5 (cs)
EG (1) EG19125A (cs)
FI (1) FI92826C (cs)
HU (1) HUT58734A (cs)
IE (1) IE902805A1 (cs)
IL (1) IL95213A (cs)
MY (1) MY105933A (cs)
NO (1) NO903420L (cs)
NZ (1) NZ234761A (cs)
PH (1) PH26568A (cs)
PL (1) PL164164B1 (cs)
PT (1) PT94888A (cs)
RU (1) RU1834889C (cs)
YU (1) YU47369B (cs)
ZA (1) ZA916126B (cs)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59198471A (ja) * 1983-04-26 1984-11-10 Canon Inc 複写装置

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059609A (en) * 1987-10-19 1991-10-22 Pfizer Inc. Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases
US5539128A (en) 1994-11-30 1996-07-23 Pfizer Inc. Processes and intermediates for preparing cis(+)3-[4,6-dihydroxy chroman-3-ylmethyl]-4-methoxyaniline
DE102014010979B3 (de) 2014-07-29 2015-11-05 Sew-Eurodrive Gmbh & Co Kg Verwendung eines Anzeigemittels eines Umrichters, Verfahren zum Betreiben eines Umrichters und Umrichter

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA739471B (en) * 1972-12-22 1974-08-28 Hoffmann La Roche Chromane derivatives
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
MX13485A (es) * 1987-10-19 1993-05-01 Pfizer Procedimiento para obtener tetralinas, cromados y compuestos relacionados, sustituidos

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59198471A (ja) * 1983-04-26 1984-11-10 Canon Inc 複写装置

Also Published As

Publication number Publication date
YU152290A (sh) 1992-09-07
KR920011021B1 (ko) 1992-12-26
NZ234761A (en) 1991-09-25
CA2022611A1 (en) 1991-02-05
HU904892D0 (en) 1991-01-28
PT94888A (pt) 1991-04-18
CZ279737B6 (cs) 1995-06-14
EP0411813A1 (en) 1991-02-06
AU613838B2 (en) 1991-08-08
FI92826C (fi) 1995-01-10
MY105933A (en) 1995-02-28
HUT58734A (en) 1992-03-30
FI92826B (fi) 1994-09-30
IE902805A1 (en) 1991-02-27
PL164164B1 (pl) 1994-06-30
PH26568A (en) 1992-08-19
CA2022611C (en) 1999-03-23
IL95213A (en) 1995-01-24
AU6019190A (en) 1991-02-07
RU1834889C (ru) 1993-08-15
DD296924A5 (de) 1991-12-19
US4987231A (en) 1991-01-22
CN1049160A (zh) 1991-02-13
ZA916126B (en) 1992-03-25
FI903861A0 (fi) 1990-08-03
PL286327A1 (en) 1991-03-25
CN1024550C (zh) 1994-05-18
KR910004610A (ko) 1991-03-29
NO903420D0 (no) 1990-08-03
EG19125A (en) 1994-07-30
NO903420L (no) 1991-02-05
YU47369B (sh) 1995-01-31
IL95213A0 (en) 1991-06-10

Similar Documents

Publication Publication Date Title
JP4795435B2 (ja) エソメプラゾール及びその塩の製造方法
EP0462776B1 (en) Preparation of optically active arylaliphatic carboxylic acids
EP0672030B1 (en) Process for preparing substantially pure enantiomers of phenylpropionic acids
JPS603387B2 (ja) 新規光学活性イミダゾリジン−２−オン誘導体およびその製法
EA012787B1 (ru) Способ получения эсциталопрама
US4546201A (en) Process for the optical resolution of (±)2-(6'methoxy-2'-naphthyl)-propionic acid
JPH0374384A (ja) ３ｒ‐（３‐カルボキシベンジル）‐６‐（５‐フルオロ‐２‐ベンゾチアゾリル）メトキシ‐４ｒ‐クロマノールの光学分割方法
US5087698A (en) Process for the optical resolution of dropopizine
CN88101200A (zh) 旋光的氧代异2氢氮茚基衍生物的制备方法
CN111777554A (zh) 一种合成苯磺顺阿曲库铵的方法
JP2001526291A (ja) アンピシリンプロドラッグエステルの溶液の精製方法
JP2776995B2 (ja) （Ｒ）−（＋）−ジヒドロ−α−イオノンの製法及びその新規中間体
US4698432A (en) Process for the resolution of (±) 2-[2'-(p-fluorophenyl)-5'-benzoxazolyl]-propionic acid
JPS59210045A (ja) シクロプロパンカルボン酸の光学活性シスおよびトランス異性体の製造方法
JPH0419215B2 (cs)
JPH0688948B2 (ja) ２―フェニルプロピオン酸エステル類の光学分割法及び光学活性２―フェニルプロピオン酸の製造法
CN119143630A (zh) 一种西酞普兰拆分工艺母液消旋化回收的方法
JP2003137835A (ja) （ｒ）−３−ヒドロキシ−３−（２−フェニルエチル）ヘキサン酸の製造方法
CN1030570C (zh) 1，5-苯并硫氮杂环庚烷衍生物类的制备方法
JPS61103852A (ja) ２−フエニルプロピオン酸エステル類の光学分割法
CN118955351A (zh) 一种氮杂环丁烷-2-羧酸乙酯的合成方法
JP2863002B2 (ja) 光学活性な２―（アルキル置換フェニル）プロピオン酸誘導体および（±）―１―メチル―３―フェニルプロピルアミンの光学分割方法
JPH0523756B2 (cs)
JPH11228480A (ja) α，ω−ジヒドロキシ−δ，（ω−３）−アルカンジオン、ω−ヒドロキシ−（ω−３）−ケト脂肪酸およびその塩、ジカルボン酸およびその塩の分離回収方法
JPS6363546B2 (cs)